Serological cross-reactivity between spotted fever and typhus groups of rickettsia infection in Japan.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
May 2023
Historique:
received: 02 11 2022
revised: 13 02 2023
accepted: 06 03 2023
medline: 11 4 2023
pubmed: 13 3 2023
entrez: 12 3 2023
Statut: ppublish

Résumé

We examined the frequency of cross-reactions to Rickettsia typhi in patients with Japanese spotted fever (JSF) and evaluated the differences between two rickettsiae using antibody endpoint titers. Patients' immunoglobulin (Ig)M and IgG titers against Rickettsia japonica and Rickettsia typhi in two phases were measured using an indirect immunoperoxidase assay at two reference centers for rickettsiosis in Japan. Cross-reaction was defined as a higher titer against R. typhi in convalescent sera than in acute sera among patients fulfilling the criteria for JSF diagnosis. The frequencies of IgM and IgG were also evaluated. Approximately 20% of cases showed positive cross-reactions. A comparison of antibody titers revealed the difficulty in identifying some positive cases. Cross-reactions of 20% in serodiagnosis may lead to the misclassification of rickettsial diseases. However, with the exception of some cases, we were able to successfully differentiate JSF from murine typhus using each endpoint titer.

Identifiants

pubmed: 36907548
pii: S1201-9712(23)00090-5
doi: 10.1016/j.ijid.2023.03.012
pii:
doi:

Substances chimiques

Immunoglobulin M 0
Immunoglobulin G 0
Antibodies, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-181

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflict of interest to declare.

Auteurs

Tetsuro Aita (T)

Department of General Internal Medicine, Fukushima Medical University, Fukushima, Japan; Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan.

Eiichiro Sando (E)

Department of General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan; Department of General Internal Medicine and Infectious Diseases, Kita-Fukushima Medical Center, Fukushima, Japan; Institute of Rickettsioses, Kita-Fukushima Medical Center, Fukushima, Japan. Electronic address: e-sando@fmu.ac.jp.

Shungo Katoh (S)

Department of General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan; Department of General Internal Medicine and Infectious Diseases, Kita-Fukushima Medical Center, Fukushima, Japan; Institute of Rickettsioses, Kita-Fukushima Medical Center, Fukushima, Japan.

Sugihiro Hamaguchi (S)

Department of General Internal Medicine, Fukushima Medical University, Fukushima, Japan.

Hiromi Fujita (H)

Institute of Rickettsioses, Kita-Fukushima Medical Center, Fukushima, Japan.

Noriaki Kurita (N)

Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH